The Blog
Options for empagliflozin in combination therapy in type 2 diabetes mellitus
Objective: To update clinicians with an overview of empagliflozin for the treatment of type 2 diabetes mellitus (T2DM), with focus on use in combination regimens. Methods: Keyword searches were conducted in the Medline database to identify literature reporting...
What’s Happening in Research
Our Research Department is always working on new and exciting projects. The patients who have participated in the 200+ research studies that collected data from our office have benefited science, the diabetic population as well as themselves. Through their dedication...
AACE: Artificial sweeteners tentatively linked to Hashimoto’s thyroiditis
NASHVILLE, TENN.– You might want to discourage your patients with Hashimoto’s thyroiditis from using artificial sweeteners, according to investigators from Mount Sinai Hospital in New York. They found that of 100 patients with antibody-confirmed Hashimoto’s...
Recent Posts
Options for empagliflozin in combination therapy in type 2 diabetes mellitusJune 3, 2016
What’s Happening in ResearchFebruary 22, 2016
AACE: Artificial sweeteners tentatively linked to Hashimoto’s thyroiditisJanuary 27, 2016